JP2012523388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012523388A5 JP2012523388A5 JP2012503993A JP2012503993A JP2012523388A5 JP 2012523388 A5 JP2012523388 A5 JP 2012523388A5 JP 2012503993 A JP2012503993 A JP 2012503993A JP 2012503993 A JP2012503993 A JP 2012503993A JP 2012523388 A5 JP2012523388 A5 JP 2012523388A5
- Authority
- JP
- Japan
- Prior art keywords
- vivo imaging
- imaging agent
- agent according
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000011503 in vivo imaging Methods 0.000 claims 19
- 239000012216 imaging agent Substances 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 7
- 239000002243 precursor Substances 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 230000002285 radioactive effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 229910052755 nonmetal Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Chemical group 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 239000012217 radiopharmaceutical Substances 0.000 claims 1
- 229940121896 radiopharmaceutical Drugs 0.000 claims 1
- 230000002799 radiopharmaceutical effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16789309P | 2009-04-09 | 2009-04-09 | |
| US61/167,893 | 2009-04-09 | ||
| GBGB0906274.6A GB0906274D0 (en) | 2009-04-09 | 2009-04-09 | Imaging the central nervous system |
| GB0906274.6 | 2009-04-09 | ||
| PCT/EP2010/054517 WO2010115881A1 (en) | 2009-04-09 | 2010-04-06 | Imaging the central nervous system with purinergic p2x7 receptor binding agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012523388A JP2012523388A (ja) | 2012-10-04 |
| JP2012523388A5 true JP2012523388A5 (enExample) | 2013-05-16 |
Family
ID=40750455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012503993A Withdrawn JP2012523388A (ja) | 2009-04-09 | 2010-04-06 | プリン作動性ｐ２ｘ７受容体結合剤を用いた中枢神経系のイメージング |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120034165A1 (enExample) |
| EP (1) | EP2416808A1 (enExample) |
| JP (1) | JP2012523388A (enExample) |
| CN (1) | CN102834120A (enExample) |
| GB (1) | GB0906274D0 (enExample) |
| WO (1) | WO2010115881A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2804801T3 (es) | 2006-12-26 | 2021-02-09 | Lantheus Medical Imaging Inc | Ligandos para la formación de imágenes de la inervación cardíaca |
| KR20170042373A (ko) | 2010-05-11 | 2017-04-18 | 랜티우스 메디컬 이메징, 인크. | 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템 |
| EP2640407A4 (en) * | 2010-11-16 | 2014-07-09 | Denis G Kay | PROCESS FOR INCREASING THE EXPRESSION AND ACTIVITY OF NEPRILYSIN |
| EP3567029A1 (en) | 2011-09-09 | 2019-11-13 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| EP3962493A2 (en) | 2019-05-03 | 2022-03-09 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007056046A1 (en) * | 2005-11-07 | 2007-05-18 | Abbott Laboratories | P2x7 receptor antagonists and methods of use |
| WO2007109154A2 (en) | 2006-03-16 | 2007-09-27 | Renovis, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| TWI464148B (zh) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途 |
| JP2009539795A (ja) | 2006-06-06 | 2009-11-19 | グラクソ グループ リミテッド | 疼痛、炎症および神経変性の治療のためのｐ２ｘ７アンタゴニストとしてのｎ−（フェニルメチル）−２−（１ｈ−ピラゾール−４−イル）アセトアミド誘導体 |
| WO2008064432A1 (en) | 2006-12-01 | 2008-06-05 | The University Of Sydney | Polycyclic molecular compounds |
| GB0803729D0 (en) * | 2008-02-29 | 2008-04-09 | Ge Healthcare Ltd | Imaging the central nervous system |
-
2009
- 2009-04-09 GB GBGB0906274.6A patent/GB0906274D0/en not_active Ceased
-
2010
- 2010-04-06 EP EP10714607A patent/EP2416808A1/en not_active Ceased
- 2010-04-06 JP JP2012503993A patent/JP2012523388A/ja not_active Withdrawn
- 2010-04-06 US US13/263,093 patent/US20120034165A1/en not_active Abandoned
- 2010-04-06 CN CN2010800164529A patent/CN102834120A/zh active Pending
- 2010-04-06 WO PCT/EP2010/054517 patent/WO2010115881A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013047277A5 (enExample) | ||
| JP2012523388A5 (enExample) | ||
| KR102527562B1 (ko) | 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템 | |
| ES2584653T3 (es) | Sonda para la obtención de imágenes de Tau | |
| RU2011138850A (ru) | Трициклические индольные производные в качестве лигандов pbr | |
| US8435489B2 (en) | Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma | |
| JP2015525782A5 (enExample) | ||
| CN106977429A (zh) | 用于合成和使用造影剂的组合物、方法和系统 | |
| JP2012504581A5 (enExample) | ||
| ES2821273T3 (es) | Compuesto derivado de 2-(3-piridinil)-1H-bencimidazol y medicamento que lo contiene | |
| CA3026889A1 (en) | Improved synthesis of the radiolabeled prostate-specific membrane antigen (psma) inhibitor [18f]dcfpyl | |
| JP2007500730A5 (enExample) | ||
| Hostetler et al. | Evaluation of [18F] MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human | |
| JP2013523621A5 (enExample) | ||
| JP2010524857A5 (enExample) | ||
| US10570124B2 (en) | Deoxycytidine kinase binding compounds | |
| JP2012520855A5 (enExample) | ||
| JP2009538894A5 (enExample) | ||
| HRP20201372T1 (hr) | Radioaktivno označeni pet mglur2/3 ligandi | |
| JP2013507345A5 (enExample) | ||
| JP2019507155A5 (enExample) | ||
| JP2012523388A (ja) | プリン作動性ｐ２ｘ７受容体結合剤を用いた中枢神経系のイメージング | |
| KR101854228B1 (ko) | 신규 아밀로이드 친화성 화합물 | |
| JP2013514319A5 (enExample) | ||
| JP6085810B2 (ja) | 放射性医薬及び医薬キット |